Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yucai Peng

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Molecular & Cellular Proteomics : MCP|January 28, 2010
Post-translational modifications differentially affect IgG1 conformation and receptor bindingDamian Houde, Yucai Peng, Steven A Berkowitz, et al.
Nanoscale|October 10, 2025
An optimized intranasal LNP formulation for potent immune responses of mRNA-based RSV vaccinesYan Li, Haiyan Long, Chunxia Wang, et al.
Biology Open|March 16, 2016
Establishment and evaluation of a transgenic mouse model of arthritis induced by overexpressing human tumor necrosis factor alphaGe Li, Yu'e Wu, Huanhuan Jia, et al.
Biology|February 23, 2024
Evaluating the Metabolic Basis of α-Gal A mRNA Therapy for Fabry DiseaseZhendong Zhang, Qi Liu, Zhiwen Deng, et al.
NPJ Vaccines|July 20, 2024
Safety and efficacy assessment of an mRNA rabies vaccine in dogs, rodents, and cynomolgus macaquesJianglong Li, Pengcheng Yu, Qi Liu, et al.
Frontiers in Immunology|September 18, 2024
Local administration of mRNA encoding cytokine cocktail confers potent anti-tumor immunityZhigang Li, Ling Hu, Yi Wang, et al.
Analytical Biochemistry|November 30, 2013
Investigation of the correlation between charge and glycosylation of IgG1 variants by liquid chromatography-mass spectrometryJia-Ming Yang, Junwen Ai, Yuemei Bao, et al.
Vaccines|January 24, 2025
An mRNA-Based Respiratory Syncytial Virus Vaccine Elicits Strong Neutralizing Antibody Responses and Protects Rodents Without Vaccine-Associated Enhanced Respiratory DiseaseJianglong Li, Haiyan Long, Shaoyi Chen, et al.
Journal of Virology|June 3, 2024
A full-length glycoprotein mRNA vaccine confers complete protection against severe fever with thrombocytopenia syndrome virus, with broad-spectrum protective effects against bandavirusesJia Lu, Jun Liu, Yan Wu, et al.
Vaccines|November 11, 2022
Development of Bivalent mRNA Vaccines against SARS-CoV-2 VariantsJianglong Li, Qi Liu, Jun Liu, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Molecular & Cellular Proteomics : MCP|January 28, 2010
Post-translational modifications differentially affect IgG1 conformation and receptor bindingDamian Houde, Yucai Peng, Steven A Berkowitz, et al.
Nanoscale|October 10, 2025
An optimized intranasal LNP formulation for potent immune responses of mRNA-based RSV vaccinesYan Li, Haiyan Long, Chunxia Wang, et al.
Biology Open|March 16, 2016
Establishment and evaluation of a transgenic mouse model of arthritis induced by overexpressing human tumor necrosis factor alphaGe Li, Yu'e Wu, Huanhuan Jia, et al.
Biology|February 23, 2024
Evaluating the Metabolic Basis of α-Gal A mRNA Therapy for Fabry DiseaseZhendong Zhang, Qi Liu, Zhiwen Deng, et al.
NPJ Vaccines|July 20, 2024
Safety and efficacy assessment of an mRNA rabies vaccine in dogs, rodents, and cynomolgus macaquesJianglong Li, Pengcheng Yu, Qi Liu, et al.
Frontiers in Immunology|September 18, 2024
Local administration of mRNA encoding cytokine cocktail confers potent anti-tumor immunityZhigang Li, Ling Hu, Yi Wang, et al.
Analytical Biochemistry|November 30, 2013
Investigation of the correlation between charge and glycosylation of IgG1 variants by liquid chromatography-mass spectrometryJia-Ming Yang, Junwen Ai, Yuemei Bao, et al.
Vaccines|January 24, 2025
An mRNA-Based Respiratory Syncytial Virus Vaccine Elicits Strong Neutralizing Antibody Responses and Protects Rodents Without Vaccine-Associated Enhanced Respiratory DiseaseJianglong Li, Haiyan Long, Shaoyi Chen, et al.
Journal of Virology|June 3, 2024
A full-length glycoprotein mRNA vaccine confers complete protection against severe fever with thrombocytopenia syndrome virus, with broad-spectrum protective effects against bandavirusesJia Lu, Jun Liu, Yan Wu, et al.
Vaccines|November 11, 2022
Development of Bivalent mRNA Vaccines against SARS-CoV-2 VariantsJianglong Li, Qi Liu, Jun Liu, et al.
Pageof 2